Science and Technology

What are exosomes?

Exosomes (also known as Extracellular Vesicles) are emerging biomarkers widely regarded as one of the most promising for cancer diagnostics and other diseases.

Exosomes are heterogeneous vesicles naturally released by all cells during their lives, especially tumour cells, and usually carry biologically active molecules, including RNA, lipids and proteins, that can deliver their messages to local or distant targets.

Mursla has developed a novel liquid biopsy platform ExoPheno   to interrogate non-invasively disease-specific target exosomes (TEX) and extract life-saving clinical insights that were not available before. 



Our exosome liquid biopsy platform: ExoPheno


ExoPheno tech flow_desktop.png
ExoPheno tech flow_mobile.png

Our exosome discovery technology

TEX Isolation

Isolation of TEX with two surface markers via proprietary tagging and release for downstream application

  • e.g. exosomes with organ specific and disease specific surface markers 

TEX Counting

TEX counting 

  • Rare subpopulation requiring a low limit of detection system

TEX Sequencing

Cargo analysis

  • Liquid chromatography mass spectrometry of TEX protein cargo

  • RNA sequencing of TEX RNA cargo

Our exosome validation technology

TEX Quantum Manipulation on Chip
TEX Electrical Sensing/Quantification
On-chip Scalable Format

Method to manipulate tagged exosomes in biofluid via quantum phenomena generated by proprietary nanogap electrodes.


Method to sense classical and non-classical electron transport once target is trapped between nanogap electrodes.

Cancer Biosensor Mursla chip.png

Millions of nanogap electrodes are stacked on a chip enabling high sensitivity and Moore's Law scalability.